Asset Details
Do you wish to reserve the book?
Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo
Do you wish to request the book?
Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo
2002
Overview
The Eph family of receptor tyrosine kinases and their ligands, known as ephrins, play a crucial role in vascular development during embryogenesis. The function of these molecules in adult angiogenesis has not been well characterized. Here, we report that blocking Eph A class receptor activation inhibits angiogenesis in two independent tumor types, the RIP-Tag transgenic model of angiogenesis-dependent pancreatic islet cell carcinoma and the 4T1 model of metastatic mammary adenocarcinoma. Ephrin-A1 ligand was expressed in both tumor and endothelial cells, and EphA2 receptor was localized primarily in tumor-associated vascular endothelial cells. Soluble EphA2-Fc or EphA3-Fc receptors inhibited tumor angiogenesis in cutaneous window assays, and tumor growth in vivo. EphA2-Fc or EphA3-Fc treatment resulted in decreased tumor vascular density, tumor volume, and cell proliferation, but increased cell apoptosis. However, EphA2-Fc had no direct effect on tumor cell growth or apoptosis in culture, yet inhibited migration of endothelial cells in response to tumor cells, suggesting that the soluble receptor inhibited blood vessel recruitment by the tumor. These data provide the first functional evidence for Eph A class receptor regulation of pathogenic angiogenesis induced by tumors and support the function of A class Eph receptors in tumor progression.
Publisher
Nature Publishing Group
Subject
/ Adenoma, Islet Cell - blood supply
/ Animals
/ Control
/ Endothelial Growth Factors - physiology
/ Endothelium, Vascular - cytology
/ Ephrins
/ Female
/ Kinases
/ Ligands
/ Mammary Neoplasms, Experimental - blood supply
/ Medicine
/ Mice
/ Neoplasms, Experimental - blood supply
/ Neoplasms, Experimental - prevention & control
/ Neovascularization, Pathologic - prevention & control
/ Platelet Endothelial Cell Adhesion Molecule-1 - analysis
/ Proliferating Cell Nuclear Antigen - analysis
/ Receptor Protein-Tyrosine Kinases - physiology
/ Tumors
/ Tyrosine
